Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.
about
Clinicopathologic characteristics of breast cancer stem cells identified on the basis of aldehyde dehydrogenase 1 expression.Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patientsFlubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.Claudin-Low Breast Cancer; Clinical & Pathological CharacteristicsThe Oct1 transcription factor and epithelial malignancies: Old protein learns new tricksThe prognostic and predictive value of the lymphocyte to monocyte ratio in luminal-type breast cancer patients treated with CEF chemotherapyBreast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.Cancer stem cells and their implication in breast cancer.The role of cancer stem cells in tumor heterogeneity and resistance to therapy.MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell.Molecular characterization of CD44+/CD24-/Ck+/CD45- cells in benign and malignant breast lesions.CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up.CD44+/CD24- phenotype predicts a poor prognosis in triple-negative breast cancer.Targeting Stemness: Implications for Precision Medicine in Breast Cancer.BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism.Quantitative evaluation of ABC transporter-mediated drug resistance based on the determination of the anticancer activity of camptothecin against breast cancer stem cells using TIRF.Prognostic Significance of CD24 in Clear Cell Renal Cell Carcinoma.
P2860
Q33875805-ACA627E7-58C8-4319-9099-D184F4F1959CQ34786571-317AAED7-F981-4D79-B192-8BD6389B38A2Q35742530-D9F5F94C-6D01-4A05-B678-046902A807E0Q36104984-11AB553B-28AE-4CC0-9CD0-F4CD5F23F7B4Q36237815-F73DE5C7-759E-4B8A-A715-2479047F6E94Q36936127-060C78C5-F224-4151-B571-85D3FE40B600Q37376414-AFF4056E-1B8C-4A85-AE81-321B88F663A0Q37707630-82E2AEF2-D5AB-42C4-AB74-96B4C489C960Q38207159-7A5FE9CF-0F22-4B6B-AB9F-E3B2ABCDE9F6Q39031410-1E82C6F5-E1C9-4B6E-9665-A742694889C3Q39281229-DBDE05EB-9F5A-4A38-8331-ABFB4AE5FC2AQ40367258-AA43B318-B35E-4570-A79B-6A7D5540E6E8Q43760118-E711B9B3-A1C3-4DA4-AA4C-E36CC6A90ECFQ47097621-131BE6A6-2989-463D-B457-76B7AB2DE9CCQ49544368-7520C048-B125-488B-9C89-4A6AEE3812C0Q50059057-8E8DD706-7F58-4D27-9267-B3AD12D88753Q51330694-18148D61-D908-4318-ABED-5C5AC7C920A8Q51395620-18638E5D-27A1-4A57-833F-47BA915D54DD
P2860
Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clinical-pathologic significan ...... on in familial breast cancers.
@en
type
label
Clinical-pathologic significan ...... on in familial breast cancers.
@en
prefLabel
Clinical-pathologic significan ...... on in familial breast cancers.
@en
P2093
P2860
P1476
Clinical-pathologic significan ...... on in familial breast cancers.
@en
P2093
Alicia Viloria-Petit
Anita Bane
Dushanthi Pinnaduwage
Frances P O'Malley
P2860
P2888
P304
P356
10.1007/S10549-013-2591-1
P407
P577
2013-06-28T00:00:00Z